| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 386 | 2021 |
| Clinical significance of nonalbuminuric renal impairment in type 2 diabetes G Penno, A Solini, E Bonora, C Fondelli, E Orsi, G Zerbini, R Trevisan, ... Journal of Hypertension 29 (9), 1802-1809, 2011 | 302 | 2011 |
| Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study G Penno, A Solini, E Bonora, C Fondelli, E Orsi, G Zerbini, R Trevisan, ... Journal of Internal Medicine 274 (2), 176-191, 2013 | 167 | 2013 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 156 | 2022 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 142 | 2021 |
| Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study RSG G.Pugliese, A.Solini, E.Bonora, C.Fondelli, E.Orsi, A.Nicolucci, G.Penno Nutrition, Metabolism and Cardiovascular Diseases 24 (8), 815-822, 2014 | 93 | 2014 |
| Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10‐year follow‐up study CL Ronchi, R Attanasio, E Verrua, R Cozzi, E Ferrante, P Loli, ... Clinical endocrinology 71 (6), 846-852, 2009 | 90 | 2009 |
| PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response A Loretelli, Cristian, Abdelsalam, F D'Addio, M Ben Nasr, E Assi, V Usuelli, ... JCI Insight, 2021 | 73 | 2021 |
| The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents I Pastore, AM Bolla, L Montefusco, ME Lunati, A Rossi, E Assi, GV Zuccotti, ... International journal of molecular sciences 21 (14), 4928, 2020 | 49 | 2020 |
| Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome L Montefusco, F D’addio, C Loretelli, M Ben Nasr, M Garziano, A Rossi, ... Journal of Endocrinological Investigation, 1-9, 2021 | 48 | 2021 |
| Improved diastolic function in type 2 diabetes after a six month liraglutide treatment F Saponaro, A Sonaglioni, A Rossi, L Montefusco, M Lombardo, G Adda, ... Diabetes research and clinical practice 118, 21-28, 2016 | 47 | 2016 |
| d3‐Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype L Montefusco, M Filopanti, CL Ronchi, L Olgiati, C La‐Porta, M Losa, ... Clinical endocrinology 72 (5), 661-667, 2010 | 46 | 2010 |
| SGLT2-inhibitors are effective and safe in the elderly: The SOLD study ME Lunati, V Cimino, A Gandolfi, M Trevisan, L Montefusco, I Pastore, ... Pharmacological Research 183, 106396, 2022 | 43 | 2022 |
| Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross … G Pugliese, A Solini, E Bonora, E Orsi, G Zerbini, C Fondelli, G Gruden, ... Cardiovascular Diabetology 13, 1-11, 2014 | 43 | 2014 |
| Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments CL Ronchi, C Giavoli, E Ferrante, E Verrua, S Bergamaschi, DI Ferrari, ... European Journal of Endocrinology 161 (1), 37-42, 2009 | 43 | 2009 |
| Indirect and direct effects of SARS-CoV-2 on human pancreatic islets M Ben Nasr, F D’Addio, L Montefusco, V Usuelli, C Loretelli, A Rossi, ... Diabetes 71 (7), 1579-1590, 2022 | 39 | 2022 |
| Use of liraglutide in the real world and impact at 36 months on metabolic control, weight, lipid profile, blood pressure, heart rate, and renal function M Rondinelli, A Rossi, A Gandolfi, F Saponaro, L Bucciarelli, G Adda, ... Clinical Therapeutics 39 (1), 159-169, 2017 | 35 | 2017 |
| Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes F D’Addio, G Sabiu, V Usuelli, E Assi, A Abdelsalam, A Maestroni, ... Diabetes 71 (8), 1800-1806, 2022 | 33 | 2022 |
| Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short-and long-term recombinant human GH … C Giavoli, E Ferrante, E Profka, L Olgiati, S Bergamaschi, CL Ronchi, ... European journal of endocrinology 163 (3), 361-368, 2010 | 28 | 2010 |
| Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis L Montefusco, S Harari, D Elia, A Rossi, C Specchia, O Torre, G Adda, ... European Journal of Internal Medicine 51, 61-67, 2018 | 25 | 2018 |